glp-1 and neuroinflammation Beyond diabetes obesity: GLP‐1 receptor agonists in disrupting the vicious cycle of metabolic dysfunction and Health Feed - Glp-1 Drugs

J Am Geriatr Soc 65(9):19881995 Rooks D, Swan T, Goswami B, Filosa LA, Bunte O, Panchaud N et al (2020) Bimagrumab vs optimized standard of care for treatment of sarcopenia in Community-Dwelling older adults: A randomized clinical trial

If youre exploring GLP-1s to improve your health, its best to do so with guidance from a qualified healthcare provider, like those at WeightWatchers Clinic

Fork head box protein A2 (FOXA2), a key transcriptional regulator of airway mucus homeostasis, is under-expressed in the airways of COPD patients, thereby inducing cupped cell proliferation and chemotaxis as well as mucus secretion

Trulicity and Others Although semaglutide and tirzepatide are some of the newer weight loss and diabetes medications to hit the market, there are a few other GLP-1s available

12,15 GLP-1 RAs have been licenced (at higher doses than those used for diabetes) for the treatment of obesity